SMMT

Summit Therapeutics Inc.

There isn't enough reported data to score SMMT yet.

UNH

UnitedHealth Group Incorporated

62
Fundamentals51/ 100
Valuation56/ 100
Upside potential71/ 100
Risk potential15/ 100

UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.

SMMT Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

SMMT's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

UNH Fundamentals

MetricStatus
Stable
Stable
Healthy
Healthy

UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

SMMT PE Valuation

SMMT has no meaningful PE right now: it lost money over the past year.

UNH PE Valuation

CHEAPFAIREXPENSIVE10x21x31x42x
CHEAPFAIREXPENSIVE10x21x31x42x
LevelPEPriceVs current
Forward18x$405—
Cheap19x$325-20%
Fair23x$410+1.2%
Current23x$405—
Expensive30x$526+30%

Historical ranges are pointers, not guarantees.

UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.

SMMT Forward outlook

MetricOutlook
--
Losses growing
Stable
--
Limited
Low

Analysts expect SMMT's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.

UNH Forward outlook

MetricOutlook
Strongly improving
Strong growth
Stable
Improving
Moderate
Low

Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.

SMMT Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $15.07 on Nov 12.

There is not enough scenario data to compare SMMT and UNH's risk to reward.

UNH Risk to reward

ScenarioChangePrice
Upside+36%$550.65
Downside-15%$346.07

Calculated from the latest close: $405.13 on Nov 12.

There is not enough scenario data to compare SMMT and UNH's risk to reward.

SMMT Earnings Per Share

Q4 2023: $-1.53Q1 2024: $-0.16Q2 2024: $-0.23Q3 2024: $-0.28Q4 2024: $-0.31Q1 2025: $-0.34Q2 2025: $-1.01Q3 2025: $-1.24Q4 2025: $-1.44Q1 2026: $-1.59Q2 2026: $-1.11Q3 2026: $-1.06
Q4 2023: $-1.53Q1 2024: $-0.16Q2 2024: $-0.23Q3 2024: $-0.28Q4 2024: $-0.31Q1 2025: $-0.34Q2 2025: $-1.01Q3 2025: $-1.24Q4 2025: $-1.44Q1 2026: $-1.59Q2 2026: $-1.11Q3 2026: $-1.06
QuarterTTM EPSYoY
Q3 2026-$1.06+$0.18
Q2 2026-$1.11-$0.10
Q1 2026-$1.59-$1.25
Q4 2025-$1.44-$1.13
Q3 2025-$1.24-$0.96
Q2 2025-$1.01-$0.78
Q1 2025-$0.34-$0.18
Q4 2024-$0.31+$1.22

SMMT lost $1.06 per share over the past year, a smaller loss than the year before.

UNH Earnings Per Share

Q4 2023: $23.86Q1 2024: $16.38Q2 2024: $15.10Q3 2024: $15.37Q4 2024: $15.51Q1 2025: $23.89Q2 2025: $23.09Q3 2025: $19.17Q4 2025: $13.23Q1 2026: $13.28Q2 2026: $15.58Q3 2026: $17.55Forward: $22.65
Q4 2023: $23.86Q1 2024: $16.38Q2 2024: $15.10Q3 2024: $15.37Q4 2024: $15.51Q1 2025: $23.89Q2 2025: $23.09Q3 2025: $19.17Q4 2025: $13.23Q1 2026: $13.28Q2 2026: $15.58Q3 2026: $17.55Forward: $22.65
QuarterTTM EPSYoY
Forward$22.65+29%
Q3 2026$17.55-8.5%
Q2 2026$15.58-33%
Q1 2026$13.28-44%
Q4 2025$13.23-15%
Q3 2025$19.17+25%
Q2 2025$23.09+53%
Q1 2025$23.89+46%
Q4 2024$15.51-35%

UNH has the edge over SMMT on earnings quality, reporting a profit while its opponent remains loss making.

SMMT Quarterly Revenue

Q4 2023: $0Q1 2024: --Q2 2024: --Q3 2024: $0Q4 2024: $0Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: $0Q1 2024: --Q2 2024: --Q3 2024: $0Q4 2024: $0Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
QuarterRevenueYoY
Q3 2022$220K-83%
Q2 2022$235K+312%
Q1 2022$250K+30%
Q4 2021$251K+36%
Q3 2021$1.3M+623%

SMMT's revenue has slid since its 2021 peak: $0 last quarter.

UNH Quarterly Revenue

Q4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $101BQ4 2024: $101BQ1 2025: $110BQ2 2025: $112BQ3 2025: $113BQ4 2025: $113BQ1 2026: $112BQ2 2026: $112BQ3 2026: $113B
Q4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $101BQ4 2024: $101BQ1 2025: $110BQ2 2025: $112BQ3 2025: $113BQ4 2025: $113BQ1 2026: $112BQ2 2026: $112BQ3 2026: $113B
QuarterRevenueYoY
Q3 2026$112.7B-0.4%
Q2 2026$112B+0.4%
Q1 2026$111.7B+2%
Q4 2025$113.2B+12%
Q3 2025$113.2B+12%
Q2 2025$111.6B+13%
Q1 2025$109.6B+9.8%
Q4 2024$100.8B+6.8%

UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.

SMMT Free Cash Flow

Q4 2023: −$19MQ1 2024: −$30MQ2 2024: −$33MQ3 2024: −$30MQ4 2024: −$49MQ1 2025: −$62MQ2 2025: −$67MQ3 2025: −$93MQ4 2025: −$102MQ1 2026: −$123MQ2 2026: −$142MQ3 2026: −$160M
Q4 2023: −$19MQ1 2024: −$30MQ2 2024: −$33MQ3 2024: −$30MQ4 2024: −$49MQ1 2025: −$62MQ2 2025: −$67MQ3 2025: −$93MQ4 2025: −$102MQ1 2026: −$123MQ2 2026: −$142MQ3 2026: −$160M
QuarterFree cash flowYoY
Q3 2026-$160.2M-$67.1M
Q2 2026-$142M-$75.3M
Q1 2026-$122.5M-$60.9M
Q4 2025-$102.1M-$53.4M
Q3 2025-$93.2M-$62.8M
Q2 2025-$66.7M-$33.7M
Q1 2025-$61.6M-$31.5M
Q4 2024-$48.7M-$29.2M

SMMT has burned cash in almost every quarter: −$527M over the past year, against −$270M the year before.

UNH Free Cash Flow

Q4 2023: −$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2026: $4.3B
Q4 2023: −$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2026: $4.3B
QuarterFree cash flowYoY
Q3 2026$4.3B-16%
Q2 2026$10.3B+63%
Q1 2026$8.1B+79%
Q4 2025$160M-89%
Q3 2025$5.1B-61%
Q2 2025$6.3B+6.9%
Q1 2025$4.6B+1037%
Q4 2024$1.5B+$7.6B

UNH has the edge over SMMT on cash generation, producing positive trailing cash flow while its opponent burns cash.

SMMT Total Shares

Q4 2023: 620MQ1 2024: 702MQ2 2024: 708MQ3 2024: 727MQ4 2024: 719MQ1 2025: 738MQ2 2025: 743MQ3 2025: 743MQ4 2025: 748MQ1 2026: 775MQ2 2026: 778MQ3 2026: 798M
Q4 2023: 620MQ1 2024: 702MQ2 2024: 708MQ3 2024: 727MQ4 2024: 719MQ1 2025: 738MQ2 2025: 743MQ3 2025: 743MQ4 2025: 748MQ1 2026: 775MQ2 2026: 778MQ3 2026: 798M
PeriodChange %Net change
Quarterly+2.6%+20M shares
1 year+7.4%+54.8M shares
3 years+14%+100M shares
5 years+781%+708M shares

SMMT has 798M diluted shares, up 7.4% from a year ago.

UNH Total Shares

Q4 2023: 938MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 929MQ1 2025: 918MQ2 2025: 910MQ3 2025: 908MQ4 2025: 911MQ1 2026: 910MQ2 2026: 906MQ3 2026: 902M
Q4 2023: 938MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 929MQ1 2025: 918MQ2 2025: 910MQ3 2025: 908MQ4 2025: 911MQ1 2026: 910MQ2 2026: 906MQ3 2026: 902M
PeriodChange %Net change
Quarterly-0.4%-4M shares
1 year-0.7%-6M shares
3 years-3.6%-34M shares
5 years-5.5%-53M shares
Available history-6.6%-64M shares

UNH has the edge over SMMT on shareholder dilution, with a more favorable share count trend.

SMMT Net Leverage

SMMT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

UNH Net Leverage

Q4 2023: 1.0xQ1 2024: 1.3xQ2 2024: 1.4xQ3 2024: 1.3xQ4 2024: 1.4xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.7xQ4 2025: 2.3xQ1 2026: 2.2xQ2 2026: 1.7xQ3 2026: 1.7x
Q4 2023: 1.0xQ1 2024: 1.3xQ2 2024: 1.4xQ3 2024: 1.3xQ4 2024: 1.4xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.7xQ4 2025: 2.3xQ1 2026: 2.2xQ2 2026: 1.7xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.7xHealthy
Q1 20262.2xModerate
Q4 20252.3xModerate
Q3 20251.7xHealthy
Q2 20251.5xHealthy
Q1 20251.3xHealthy
Q4 20241.4xHealthy

UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.

SMMT Weekly Momentum

MetricValueStatus
RSI47.2Neutral
Stochastic53.3Neutral

SMMT's weekly RSI is 47 (neutral) and its Stochastic is 53 (neutral).

UNH Weekly Momentum

MetricValueStatus
RSI56.4Neutral
Stochastic60.0Neutral

UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).

SMMT PE vs Healthcare Sector

SMMT has no meaningful PE right now: it lost money over the past year.

UNH PE vs Healthcare Sector

MetricUNHSector medianRelative
PE23x26x11% below
PE %472918 pts above

UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.

SMMT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$15.95.5% below
20 week MA$15.31.4% below
50 week MA$16.37.8% below
100 week MA$19.021% below
200 week MA$12.619% above

SMMT has fallen below most of its moving averages, though it's still 19% above its 200-week average.

UNH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$394.22.8% above
20 week MA$400.51.2% above
50 week MA$361.212% above
100 week MA$376.07.8% above
200 week MA$446.69.3% below

UNH has the edge over SMMT on trend strength, trading above more of its moving averages.

SMMT Yearly ROI

YearStart priceEnd priceROI
2020$1.55$5.70+268%
2021$5.70$3.03-47%
2022$3.03$3.67+21%
2023$3.67$2.61-29%
2024$2.61$18.2+598%
2025$18.2$18.1-0.4%
2026 YTD$18.1$15.1-17%

SMMT's yearly returns have swung widely, from +598% in 2024 to −47% in 2021. It's down 17% so far in 2026.

UNH Yearly ROI

YearStart priceEnd priceROI
2020$296.0$340.8+15%
2021$340.8$495.4+45%
2022$495.4$531.3+7.3%
2023$531.3$526.5-0.9%
2024$526.5$510.0-3.1%
2025$510.0$331.8-35%
2026 YTD$331.8$405.1+22%

UNH has the edge over SMMT on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key